한글목차

세계의 디지털 백신 시장 규모는 2024년에 12억 8,000만 달러로 평가되었고, 2030년에는 20억 3,000만 달러에 이를것으로 예측되며, CAGR 7.98%로 성장할 것으로 전망됩니다.

디지털 백신은 소프트웨어 기반 플랫폼을 활용하여 면역 반응을 조절하는 신경 인지 및 행동 경로에 관여하는 예방 의료 분야의 획기적인 기술입니다. 기존 백신과 달리 이러한 디지털 솔루션은 스마트폰, 태블릿, 웨어러블 기기를 사용하여 감염병, 만성 질환, 정신 건강 상태를 대상으로 비침습적인 맞춤형 개입을 제공합니다. 이 시장은 디지털 의료 기술이 발전하고 개인화되고 확장 가능한 예방 방법에 대한 수요가 증가함에 따라 주목받고 있습니다. 전 세계적으로 증가하는 의료 수요와 데이터 기반의 통합 의료 서비스 제공으로의 전환이 시장의 확장을 뒷받침하고 있습니다. 디지털 치료와 예방 접종의 교차점에 위치한 디지털 백신은 혁신적이고 비용 효율적인 예방 치료 솔루션을 통해 미래의 공중 보건 전략을 재편하고 있습니다.

시장 성장 촉진요인

감염성 및 만성 질환의 발생률 증가

주요 시장 과제

규제 불확실성 및 복잡한 승인 절차

주요 시장 동향

디지털 백신과 광범위한 디지털 치료 생태계의 통합

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 디지털 백신 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율 및 예측
  • 기기 유형별(스마트폰, 태블릿, 기타)
  • 용도별(당뇨병, 감염증, 심혈관 질환, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 디지털 백신 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 디지털 백신 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 디지털 백신 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 디지털 백신 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 디지털 백신 시장 전망

• 시장 규모와 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제13장 세계 디지털 백신 시장 : SWOT 분석

제14장 경쟁 구도

• Pfizer Inc.
• Moderna, Inc
• AstraZeneca Plc
• Johnson & Johnson Service Inc.
• Sanofi
• GSK Plc.
• Novavax
• BioNTech SE
• Bharat Biotech Ltd
• Klein Buendel, Inc

제15장 전략적 제안

영문목차

The Global Digital Vaccine Market was valued at USD 1.28 Billion in 2024 and is projected to reach USD 2.03 Billion by 2030, growing at a CAGR of 7.98%. Digital vaccines represent a breakthrough in preventive healthcare, utilizing software-based platforms to engage neurocognitive and behavioral pathways for modulating immune responses. Unlike conventional vaccines, these digital solutions employ smartphones, tablets, and wearable devices to deliver non-invasive, customized interventions targeting infectious diseases, chronic illnesses, and mental health conditions. This market is gaining traction as digital health technologies evolve and the demand for personalized, scalable prevention methods rises. Increasing global healthcare needs, coupled with the shift towards integrated, data-driven care delivery, support the market's expansion. Positioned at the intersection of digital therapeutics and immunization, digital vaccines are reshaping future public health strategies through innovative, cost-effective preventive care solutions.

Key Market Drivers

Rising Incidence of Infectious and Chronic Diseases

The growing prevalence of infectious and chronic diseases is a primary catalyst propelling the Global Digital Vaccine Market. In 2021, non-communicable diseases accounted for over 43 million deaths, with 18 million classified as premature. These statistics are particularly concerning in low- and middle-income countries, where 82% of early deaths occurred. Concurrently, communicable diseases like tuberculosis, COVID-19, and influenza continue to impact global health, with TB alone causing 1.25 million deaths in 2023. The escalating burden on healthcare systems underscores the urgent need for preventive, scalable solutions. Digital vaccines offer timely, personalized interventions using software to manage and mitigate disease progression, thereby addressing a critical gap in traditional healthcare infrastructure.

Key Market Challenges

Regulatory Uncertainty and Complex Approval Processes

The absence of clear regulatory standards tailored for digital vaccines presents a considerable challenge for market growth. These software-based interventions straddle multiple domains-therapeutics, digital health, and preventive care-leading to ambiguity in classification and compliance. Regulatory bodies around the world differ in their evaluation and approval processes, which results in delays, inconsistent requirements, and elevated development costs. These factors deter investment, complicate commercialization, and hinder broader market adoption, especially in emerging regions.

Key Market Trends

Integration of Digital Vaccines with Broader Digital Therapeutics Ecosystems

A notable trend in the market is the merging of digital vaccines into comprehensive digital therapeutic ecosystems. Instead of operating as isolated tools, digital vaccines are increasingly becoming components of integrated health platforms that include AI diagnostics, remote monitoring, and personalized treatment. This ecosystem-based approach enhances clinical effectiveness through real-time analytics and interconnected care pathways. By fostering interoperability and cross-platform functionality, companies that prioritize ecosystem integration are poised to drive adoption and deliver greater value in preventive health.

Key Market Players

• Pfizer Inc.
• Moderna, Inc
• AstraZeneca Plc
• Johnson & Johnson Service Inc.
• Sanofi
• GSK Plc.
• Novavax
• BioNTech SE
• Bharat Biotech Ltd
• Klein Buendel, Inc

Report Scope:

In this report, the Global Digital Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Vaccine Market, By Device Type:

• Smartphones
• Tablets
• Others

Digital Vaccine Market, By Application:

• Diabetes
• Infectious Diseases
• Cardiovascular Diseases
• Others

Digital Vaccine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Vaccine Market.

Available Customizations:

Global Digital Vaccine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Digital Vaccine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Smartphones, Tablets, Others)
  • 5.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Digital Vaccine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital Vaccine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Digital Vaccine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Digital Vaccine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Application

7. Europe Digital Vaccine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Digital Vaccine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Digital Vaccine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Digital Vaccine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Application
  • 7.3.4. France Digital Vaccine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Digital Vaccine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Digital Vaccine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Digital Vaccine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Digital Vaccine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Digital Vaccine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Digital Vaccine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Digital Vaccine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Application

9. South America Digital Vaccine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Digital Vaccine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Digital Vaccine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Digital Vaccine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Digital Vaccine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Digital Vaccine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Digital Vaccine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Digital Vaccine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Digital Vaccine Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Pfizer Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Moderna, Inc
• 14.3. AstraZeneca Plc
• 14.4. Johnson & Johnson Service Inc.
• 14.5. Sanofi
• 14.6. GSK Plc.
• 14.7. Novavax
• 14.8. BioNTech SE
• 14.9. Bharat Biotech Ltd
• 14.10.Klein Buendel, Inc

15. Strategic Recommendations